Infusion System Market Research Report By Product Type (Iv Disposable, Infusion Pump, Others); By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics, And Others); By End User (Hospitals, Specialty Oncology Wards, Homecare) - Forecast To 2032

Infusion System Market Overview

The infusion system market is projected to reach USD 12.81 Billion by 2032 at 8.9% CAGR during the forecast period 2023-2032. An infusion system is basically an infusion pump that is widely used to infuse fluids nutrients or medication into the body of the patient’s circulatory system. It is widely used intravenously and it is occasionally used for epidural and arterial infusions as well. It is generally used to manage or treat neurological disorders or conditions of the nervous system.

There are several factors that are a contribution to the growth of the global infusion system market such as the increased demand for the infusion pumps for infusing drugs or other essential fluids, increasing prevalence of fatal diseases and chronic diseases, the rise in demand for the infusion pumps in the military units o medical, advancement in technology of these surgical drug infusion system from the key players of the market. However, the concerns about the consequences of the systems and the low-income countries that can’t afford to supply such systems to their medical units are the major causes that are creating hurdles in the growth of the global infusion system global market. 

This report contains all the information on the global infusion system market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global infusion system market report and forecast to 2025 is also included in the report.

Covid 19 Analysis
The outbreak of the global pandemic has led numerous health workers to resort to place infusion systems outside the patient so that they can manage the medications of the patients from several feet away. The immune system infusion therapy is widely used for the hospitalized covid 19 patients is vital in the global infusion system market. Moreover, the outbreak of the covid 19 has left a positive impact on the global infusion system market and it is expected to add fuel to the growth of the infusion system market.  

Infusion System Market Trends

• Drivers

The rising incidence of cardiovascular diseases and chronic diseases leading to diabetes are the major factors that are driving the growth of the global infusion system market during the forecast period 2020 to 2025. Moreover, the rising patients of with diabetes and their adaptation to different types of infusion pumps are raising the demands for the infusion system market during the forecast period.

• Opportunities

The benefit of the intravenous infusion system in administering medication, amino acids, minerals, and several essential micronutrients can create opportunities infusion system market by adding to the infusion for collateral nutrition. Smart infusion systems are technologically advanced with automation, drug libraries, operators, and the safety features for accurate and precise results of patients, it also helps in delivering controlled fluids into the patient systems.

• Restraints

The improper disposable infusion pumps and the rising concerns about the safety of patients are leading to create several consequences and unmet needs of medical in the low-income countries are likely to hamper the growth of the global infusion system market.

• Challenges

The stringent regulation of governments for launching new device approval is the major factor that is restraining the infusion systems market during the forecast period 2020 to 2025. Furthermost, the U.S Foods and Drugs Administration has written a letter to the manufacturers of infusion systems where they are describing the problems related to the controlled release infusion system which serves as a major setback for the growth of the global infusion system market.

Cumulative Growth Analysis

North America is predicted to rule the major drug infusion market size due to the rapid rise in the technological advancement of the developed countries. North America is predicted to influence USD 3.49 Billion by the end of the year 2023.

Value Chain Analysis

According to the latest report, the global infusion system market has been segmented on the basis of product type which comprises IV disposable, infusion pump, and others. IV disposable accounts for the maximum market share of the total market revenue in 2016. On the basis of application, the global infusion system market has been segmented into gastrointestinal diseases, chemotherapy, diabetes, pediatrics, and others. The chemotherapy segment accounts for the maximum infusion system share of the total market in the year 2016.

On the basis of end-users, the global infusion system market has been segmented into specialist oncology wards, hospitals, homecare, others. A hospital segment is expected to dominate the global infusion system market with the maximum market share in the year 2016.

Infusion System Market Segment Insights

The market is segmented on the basis of product type which comprises of IV disposable, infusion pump, and others. The global infusion system market is expected to witness decent growth during the forecast period.

Infusion System Application Insights

Based on the application, the market is segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders.

Infusion System End-Users Insights

Based on the propulsion types, the market is segmented into diagnostic centers, and hospitals & clinics.

Infusion System Regional Insights

According to the reports, on the basis of region, the global infusion system market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest infusion system market and it is predicted to commands the largest share in the market due to rising advanced technologies in this region. Europe held the second-largest share in the market followed by Asia pacific and this region offers lots of opportunities due to the continuously growing economies of the countries in this region. The developments of health care sectors and improvised economies and increased disposable income per individual are the major factors that are boosting the demand for the infusion systems in this region. The Middle East and Africa are less developed economies and exceptionally low-income accounts for the minimum market share in the year 2016 but it is predicted to grow with better infusion treatment in the countries.

Competitive landscape

The prominent key players of the global infusion system market companies are focused on making strategies through innovation, developments in products, and mergers & acquisitions.

Major Key Players

•    Becton


•    Dickinson and Company (US)


•    B. Braun Melsungen AG (Germany)


•    Baxter International Inc. (US)


•    Fresenius Kabi (Germany)


•    ICU Medical, Inc. (US)


•    Medtronic plc (Ireland), Moog Inc. (US)


•    Smiths Medical (US)


•    Terumo Corporation (Japan)


•    NIPRO Corporation (Japan)


•    Avanos Medical, Inc. (US)


•    Tandem Diabetes Care, Inc. (US)


•    JMS Co., Ltd. (Japan)


•    Insulet Corporation (US)


•    Roche Diagnostics (Switzerland)


•    Zyno Medical (US)


•    Teleflex, Inc. (US)


•    Mindray Medical International Limited (China)


•    Micrel Medical Devices SA (Greece)


•    Ypsomed Holding AG (Switzerland).

Report Overview
The following report comprises of –

•         Market overview 


•         Covid 19 Analysis


•         Market Dynamic


•         Drivers


•         Opportunities


•         Restraints 


•         Challenges


•         Cumulative Growth Analysis


•         Value Chain Analysis


•         Segmentation Overview 


•         By Application 


•         By End-Users


•         Regional Analysis


•         Competitive landscape

Recenet Developments

• In January 2020, Medtronic (Ireland) Launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.

Infusion System Market Segmentation

Infusion System Product Outlook

• Accessories & Consumables
  
  
  
  • Dedicated Accessories & Consumables
    
    
    
    • Volumetric Infusion Pumps
    
    
    • Insulin Infusion Pumps
    
    
    • Enteral Infusion Pumps
    
    
    • Syringe Infusion Pumps
    
    
    • Ambulatory Infusion Pumps
    
    
    • PCA Pumps
    
    
    • Implantable Infusion Pumps
    
    
    
    
  
  
  
  




• Non-Dedicated Accessories & Consumables
  
  
  
  • Infusion Catheters
  
  
  • IV/Administration Sets
  
  
  • Needleless Connectors
  
  
  • Cannulas
  
  
  • Tubing & Extension Sets
  
  
  • Valves
  
  
  • Other Non-dedicated Accessories & Consumables
  
  
  
  








• Devices
  
  
  
  • By Product
    
    
    
    • Volumetric Infusion Pumps
    
    
    • Enteral Infusion Pumps
    
    
    • Ambulatory Infusion Pumps
      
      
      
      • Disposable Infusion Pumps
      
      
      • Chemotherapy Infusion Pumps
      
      
      
      
    
    
    
    
  
  
  
  
  • Syringe Infusion Pumps
  
  
  
  
  
  
  • Insulin Infusion Pumps
  
  
  
  
  
  
  • PCA Pumps
  
  
  
  
  
  
  • Implantable Infusion Pumps
  
  
  
  
  
  




• By Type
  
  
  
  • Traditional Infusion Pumps
  
  
  • Specialty Infusion Pumps
  
  
  
  

Infusion System Application Outlook

• Chemotherapy/Oncology


• Diabetes


• Gastroenterology


• Analgesia/Pain Management


• Pediatrics/Neonatology


• Hematology


• Other Applications

Infusion System End User Outlooks

• Hospitals


• Home Care Settings


• Ambulatory Care Settings


• Academic & Research Institutes

Infusion System Region Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  






• Europe
  
  
  
  • Germany
  
  
  • UK
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe (RoE)
  
  
  
  






• Asia Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Rest of Asia Pacific (RoAPAC)
  
  
  
  






• Latin America
  
  
  
  • Brazil
  
  
  • Mexico
  
  
  • Rest of Latin America (RoLA)
  
  
  
  






• Middle East & Africa

Attribute/Metric	Details
Market Size 2022	N/A (USD Billion)
Market Size 2023	N/A (USD Billion)
Market Size 2032	12.81 (USD Billion)
Compound Annual Growth Rate (CAGR)	8.9 % (2024- 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2022
Market Forecast Period	2023 - 2032
Historical Data	2019 - 2022
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	3M, B. BRAUN MELSUNGEN AG, Baxter, Becton, Dickinson and Company, Fresenius Kabi AG, ICU Medical, Inc, Smiths Medical, and Terumo Medical Corporation
Key Market Opportunities	Joint ventures, strategic alliances, mergers and acquisitions, new product developments
Key Market Drivers	·  Rising prevalence of chronic and fatal diseases ·  high demand of the infusion systems in the military medical units